Showing results (281-290 of 458) with videos related to

Sort By:
Pageof 46
Journal of the National Cancer Institute|October 15, 2010
Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infectionsMahboobeh Safaeian, Carolina Porras, Mark Schiffman, et al.
Obstetrics and Gynecology|November 9, 2016
Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical GuidelinesJulia C Gage, William C Hunt, Mark Schiffman, et al.
International Journal of Cancer|March 13, 2019
Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotestingRebecca Landy, Mark Schiffman, Peter D Sasieni, et al.
Journal of Lower Genital Tract Disease|September 28, 2017
Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening GuidelinesMaria Demarco, Thomas S Lorey, Barbara Fetterman, et al.
International Journal of Cancer|April 11, 2012
Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and managementNicolas Wentzensen, Joan Walker, Mark Schiffman, et al.
American Journal of Obstetrics and Gynecology|February 20, 2016
Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatmentAllan Hildesheim, Paula Gonzalez, Aimee R Kreimer, et al.
International Journal of Cancer|August 1, 2012
Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasiaLisa Mirabello, Mark Schiffman, Arpita Ghosh, et al.
The Journal of Experimental Medicine|April 6, 2005
Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen lociMary Carrington, Sophia Wang, Maureen P Martin, et al.
Gynecologic Oncology|November 14, 2012
The role of co-factors in the progression from human papillomavirus infection to cervical cancerPatricia Luhn, Joan Walker, Mark Schiffman, et al.
Pageof 46